Faruqi & Faruqi, LLP, a leading national securities firm headquartered in New York City, is investigating the Board of Directors of RehabCare Group, Inc. (“RehabCare” or the “Company”) (NYSE: RHB) for potential breaches of fiduciary duties in connection with their conduct related to the sale of the Company to Kindred Healthcare, Inc. (“Kindred”) (NYSE: KND) for an estimated $900 million. The proposed transaction only offers RehabCare shareholders $26.00 in cash and 0.471 shares of Kindred for each of their shares. Kindred plans to issue approximately 12 million shares in connection with the deal. The transaction is subject to approval by shareholders and expected to close on or a bout June 30, 2011.
Request more information now by clicking here: www.faruqilaw.com/RHB
Whether the RehabCare’s Board of Directors breached their fiduciary duties to RehabCare’s stockholders by failing to conduct an adequate and fair sales process to sell the Company prior to agreeing to this proposed transaction, whether the proposed transaction undervalues RehabCare’s shares and by how much this proposed transaction undervalues the Company to the detriment of RehabCare shareholders are the key focus of this investigation.
Faruqi & Faruqi, LLP is a national law firm which represents investors and individuals in class action litigation. The firm is focused on providing exemplary legal services in complex litigation in the areas of securities, shareholder, antitrust and consumer litigation, through all phases of litigation. The firm has an experienced trial team which has achieved significant victories on behalf of the firm’s clients.If you own common stock in RehabCare and wish to obtain additional information, please visit us at www.faruqilaw.com/RHB or contact Juan E. Monteverde, Esq. either via e-mail at firstname.lastname@example.org or by telephone at (877) 247-4292 or (212) 983-9330. Attorney Advertising. (C) 2011 Faruqi & Faruqi, LLP. The law firm responsible for this advertisement is Faruqi & Faruqi, LLP ( www.faruqilaw.com). Prior results do not guarantee or predict a similar outcome with respect to any future matter. We are happy to discuss your particular case.